H.R.2544 - Medical Independence, Privacy, and Innovation Act of 2003108th Congress (2003-2004)
|Sponsor:||Rep. Rohrabacher, Dana [R-CA-46] (Introduced 06/19/2003)|
|Committees:||House - Ways and Means; Energy and Commerce; Judiciary|
|Latest Action:||09/04/2003 Referred to the Subcommittee on Courts, the Internet, and Intellectual Property. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
Summary: H.R.2544 — 108th Congress (2003-2004)All Information (Except Text)
Medical Independence, Privacy, and Innovation Act of 2003 - Amends the Internal Revenue Code to eliminate language making the medical expense deduction only apply to the extent the relevant expenses exceed 7.5 percent of adjusted gross income. Permits the deduction in computing adjusted gross income.
Introduced in House (06/19/2003)
Exempts medical checking accounts from being subjected to certain taxes. Subjects such accounts to taxes on unrelated business income of charitable organizations. Allows a deduction equal to the amount paid in cash to an individual's medical checking account (up to $1,000, or $2,000 in the case of a joint return) and a credit (of up to $1,000) for contributions made to such account.
Excludes from gross income any amount paid or distributed out of a medical checking account which is used exclusively to pay qualified medical expenses of any account holder.
Decreases the minimum annual deductibles under a high deductible health plan for purposes of Archer medical savings accounts.
Makes modifications to regulations regarding the privacy of individually identifiable health information.
Prohibits the granting of an exclusive or partially exclusive license regarding an invention made with Federal assistance, except in accordance with specified provisions of Federal law pertaining to the licensing of Federally owned inventions.
Amends the Federal Food, Drug, and Cosmetic Act to direct the Secretary to promulgate regulations permitting pharmacists and wholesalers to import prescription drugs from foreign nations, with such regulations to require that each such drug complies with sections of the Act pertaining to new drugs, adulterated drugs and devices, and misbranded drugs and devices, and with other applicable requirements of this Act. (Current law directs the Secretary to promulgate regulations permitting pharmacists and wholesalers to import prescription drugs, except for specified controlled substances and biological products).